The ErbB/HER family of protein-tyrosine kinases and cancer

2014/01/01 by Robert Roskoski · 1 citation

paper · doi:10.1016/j.phrs.2013.11.002

Cited by

• EGFR- and HER3-targeted bispecific antibody-drug conjugate demonstrates antitumor activity in metastatic castration-resistant prostate cancer